# The Exploratory Study on the Biological Function of Dendritic Cells In Vivo Supported by Nicotinamide Mononucleotide (Vital NAD)

> **NCT06036355** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shanghai Cell Therapy Group Co.,Ltd** · enrollment: 20 (estimated)

## Conditions studied

- Postoperative Prevention of Tumor

## Interventions

- **DRUG:** Oral NMN combined with DC cell vaccine

## Key facts

- **NCT ID:** NCT06036355
- **Lead sponsor:** Shanghai Cell Therapy Group Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-30
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06036355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06036355, "The Exploratory Study on the Biological Function of Dendritic Cells In Vivo Supported by Nicotinamide Mononucleotide (Vital NAD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06036355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*